Advances in omics technologies for traditional Chinese medicine in the prevention and treatment of metabolic bone diseases
Open Access
- 11 April 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1576286
Abstract
Metabolic bone disease (MBD), as one of the most severe metabolic disorders, remains a focal point and challenge in medical research. Numerous studies have demonstrated the efficacy of Traditional Chinese Medicine (TCM) in preventing and treating MBD. However, the inherent complexity of TCM metabolites poses significant limitations in elucidating their mechanisms of action. The advancement of omics technologies, including metabolomics, proteomics, and transcriptomics, has greatly facilitated research on MBD. These approaches enable the identification of potential biomarkers and the exploration of metabolic pathways and mechanisms underlying TCM interventions for MBD. Evidence indicates that TCM monomers, single botanical drugs, and herbal formulations are effective, safe, and well-tolerated in MBD prevention and treatment. This review summarizes recent applications and key findings of transcriptomics, proteomics, and metabolomics in studying the mechanisms of TCM interventions for MBD. It highlights the role of omics technologies in uncovering relevant metabolites and pathways under TCM treatment, providing valuable insights and clinical references for TCM-based strategies in managing MBD.Keywords
This publication has 83 references indexed in Scilit:
- Bone metabolism in diabetes: a clinician’s guide to understanding the bone–glucose interplayDiabetologia, 2024
- Bajitianwan formula extract ameliorates bone loss induced by iron overload via activating RAGE/PI3K/AKT pathway based on network pharmacology and transcriptomic analysisJournal of Natural Medicines, 2024
- Transcriptomic analysis the mechanisms of anti-osteoporosis of desert-living Cistanche herb in ovariectomized rats of postmenopausal osteoporosisFunctional & Integrative Genomics, 2023
- UPLC/Q‐TOF–MS‐based metabolomics evaluate the efficacy of oroxylin A against postmenopausal osteoporosisBiomedical Chromatography, 2023
- TMT‐based proteomics analysis to screen potential biomarkers of Achyranthis Bidentatae Radix for osteoporosis in ratsBiomedical Chromatography, 2022
- Potential Biomarkers of the Turnover, Mineralization, and Volume Classification: Results Using NMR Metabolomics in Hemodialysis PatientsJBMR Plus, 2020
- Comparative proteomics analysis of microvesicles in human serum for the evaluation of osteoporosisElectrophoresis, 2019
- Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methodsOsteoporosis International, 2019
- Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and TreatmentsCurrent Osteoporosis Reports, 2019
- Kidney tissue targeted metabolic profiling of glucocorticoid‐induced osteoporosis and the proposed therapeutic effects of Rhizoma Drynariae studied using UHPLC/MS/MSBiomedical Chromatography, 2014